| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.46 | 0.01 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.41 | 0.05 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.37 | 0.08 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.37 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.25 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.23 | 0.3 |